Viewing StudyNCT06169579



Ignite Creation Date: 2024-05-06 @ 7:52 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06169579
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-03-21
First Post: 2023-11-23

Brief Title: An Open-label Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers
Sponsor: Shenzhen NewDEL Biotech Co Ltd
Organization: Shenzhen NewDEL Biotech Co Ltd

Organization Data

Organization: Shenzhen NewDEL Biotech Co Ltd
Class: INDUSTRY
Study ID: ND-003-I
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Shenzhen NewDEL Biotech Co Ltd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Shenzhen Innovation Center for Small Molecule Drug Discovery Co Ltd UNKNOWN